Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results

بواسطة Passardi, Alessandro, Fanini, Francesca, Turci, Livia, Foca, Flavia, Rosetti, Paola, Ruscelli, Silvia, Casadei Gardini, Andrea, Valgiusti, Martina, Dazzi, Claudio, Marangolo, Maurizio
الحاوية / القاعدة Oncologist (2017)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

بواسطة Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, Pasquini Enzo, Dazzi Claudio, Dall'Agata Monia, Cecconetto Lorenzo, Passardi Alessandro, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino
منشور في 2008-10-01

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

بواسطة Passardi, Alessandro, Cecconetto, Lorenzo, Dall'Agata, Monia, Dazzi, Claudio, Pasquini, Enzo, Oliverio, Giovanni, Zumaglini, Federica, Zoli, Wainer, Nanni, Oriana, Milandri, Carlo, Frassineti, Giovanni Luca, Amadori, Dino
منشور في 2008

Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR)

بواسطة Chiadini, Elisa, Canale, Matteo, Delmonte, Angelo, Dazzi, Claudio, Casanova, Claudia, Capelli, Laura, Mariotti, Marita, Papi, Maximilian, Gamboni, Alessandro, Puccetti, Maurizio, Bravaccini, Sara, Dubini, Alessandra, Calistri, Daniele, Crinò, Lucio, Ulivi, Paola
الحاوية / القاعدة J Thorac Dis (2018)

Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

بواسطة Gelsomino, Francesco, Tiseo, Marcello, Barbieri, Fausto, Riccardi, Ferdinando, Cavanna, Luigi, Frassoldati, Antonio, Delmonte, Angelo, Longo, Lucia, Dazzi, Claudio, Cinieri, Saverio, Colantonio, Ida, Sperandi, Francesca, Lamberti, Giuseppe, Brocchi, Stefano, Tofani, Lorenzo, Boni, Luca, Ardizzoni, Andrea
الحاوية / القاعدة Br J Cancer (2020)

Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

بواسطة Gelsomino, Francesco, Tiseo, Marcello, Barbieri, Fausto, Riccardi, Ferdinando, Cavanna, Luigi, Frassoldati, Antonio, Delmonte, Angelo, Longo, Lucia, Dazzi, Claudio, Cinieri, Saverio, Colantonio, Ida, Sperandi, Francesca, Lamberti, Giuseppe, Brocchi, Stefano, Tofani, Lorenzo, Boni, Luca, Ardizzoni, Andrea
الحاوية / القاعدة Br J Cancer (2021)

Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?

بواسطة Ulivi, Paola, Delmonte, Angelo, Chiadini, Elisa, Calistri, Daniele, Papi, Maximilian, Mariotti, Marita, Verlicchi, Alberto, Ragazzini, Angela, Capelli, Laura, Gamboni, Alessandro, Puccetti, Maurizio, Dubini, Alessandra, Burgio, Marco Angelo, Casanova, Claudia, Crinò, Lucio, Amadori, Dino, Dazzi, Claudio
الحاوية / القاعدة Int J Mol Sci (2014)

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-vo...

بواسطة Brandes, Alba A., Franceschi, Enrico, Ermani, Mario, Tosoni, Alicia, Albani, Fiorenzo, Depenni, Roberta, Faedi, Marina, Pisanello, Anna, Crisi, Girolamo, Urbini, Benedetta, Dazzi, Claudio, Cavanna, Luigi, Mucciarini, Claudia, Pasini, Giuseppe, Bartolini, Stefania, Marucci, Gianluca, Morandi, Luca, Zunarelli, Elena, Cerasoli, Serenella, Gardini, Giorgio, Lanza, Giovanni, Silini, Enrico Maria, Cavuto, Silvio, Baruzzi, Agostino
الحاوية / القاعدة Neurooncol Pract (2014)